CENCORA
LIVE

Serial Number

98330239

Owner

Cencora, Inc.

Attorney

Anita B. Polott

Filing Date

Dec 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CENCORA Trademark

Serial Number: 98330239

CENCORA is a trademark filed by Cencora, Inc. on December 26, 2023. The trademark is classified under Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

Cencora, Inc. (74 trademarks)

1 West First Avenue
Conshohocken, PA 19428

Entity Type: 03

Trademark Details

Filing Date

December 26, 2023

Registration Date

Not Registered

Published for Opposition

November 26, 2024

Goods & Services

Legal services; Public document filing assistance in the field of medicine authorization, namely, public document filing services pertaining to documents for authorizing medicines and filing documents, reports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals; Regulatory compliance consulting in the field of clinical trials, pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products; Regulatory research in the field of health care; Regulatory compliance auditing; regulatory compliance consulting services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; regulatory support and advice, namely, regulatory compliance consulting in the field of drug approval; regulatory compliance auditing in the nature of submission of documents, reports and records required for drug approval by regulatory authorities; consultancy services in the fields of regulatory compliance and oversight in the field of pharmaceuticals, medical devices, and biopharmaceuticals; advisory services relating to regulatory compliance auditing; regulatory maintenance of marketing authorizations, namely, tracking and monitoring regulatory requirements in the field of pharmaceuticals for regulatory compliance purposes following pharmaceutical approval

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 7, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 7, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 7, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 3, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 11, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 29, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 6, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 6, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2024 CNRT
ASSIGNED TO EXAMINER
May 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2024 NWOS
NEW APPLICATION ENTERED
Dec 26, 2023 NWAP